Cerevel Therapeutics’ $350 Million Public Offering

Martina Bellini
Tagged:

Goodwin Procter advised Cerevel Therapeutics on the deal.Cerevel Therapeutics (Nasdaq: CERE) announced its underwritten public offering of 14,000,000 shares of common stock at a public offering price…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now